Literature DB >> 26303674

Coeliac disease and autoimmune disease-genetic overlap and screening.

Knut E A Lundin1, Cisca Wijmenga2.   

Abstract

Coeliac disease is a treatable, gluten-induced disease that often occurs concurrently with other autoimmune diseases. In genetic studies since 2007, a partial genetic overlap between these diseases has been revealed and further insights into the pathophysiology of coeliac disease and autoimmunity have been gained. However, genetic screening is not sensitive and specific enough to accurately predict disease development. The current method to diagnose individuals with coeliac disease is serological testing for the presence of autoantibodies whilst the patient is on a regular, gluten-containing diet, followed by gastroduodenoscopy with duodenal biopsy. Serological test results can also predict the probability of coeliac disease development, even if asymptomatic. In patients with autoimmune diseases known to occur alongside coeliac disease (particularly type 1 diabetes mellitus or thyroid disorders), disease screening-and subsequent treatment if coeliac disease is detected-could have beneficial effects on progression or potential complications of both diseases, owing to the effectiveness of gluten-free dietary interventions in coeliac disease. However, whether diagnosis of coeliac disease and subsequent dietary treatment can prevent autoimmune diseases is debated. In this Review, the genetic and immunological features of coeliac disease, overlap with other autoimmune diseases and implications for current screening strategies will be discussed.

Entities:  

Mesh:

Year:  2015        PMID: 26303674     DOI: 10.1038/nrgastro.2015.136

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  128 in total

1.  No effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease. Retrospective and controlled prospective survey.

Authors:  K Kaukinen; J Salmi; J Lahtela; U Siljamäki-Ojansuu; A M Koivisto; H Oksa; P Collin
Journal:  Diabetes Care       Date:  1999-10       Impact factor: 19.112

2.  Relationship of HLA-DQ8 and severity of celiac disease: comparison of New York and Parisian cohorts.

Authors:  Timothy C Johnson; Beverly Diamond; Lorenzo Memeo; Horia Negulescu; Zara Hovhanissyan; Virginie Verkarre; Heidrun Rotterdam; Alessio Fasano; Sophie Caillat-Zucman; Etienne Grosdidier; Robert Winchester; Christophe Cellier; Bana Jabri; Peter H R Green
Journal:  Clin Gastroenterol Hepatol       Date:  2004-10       Impact factor: 11.382

Review 3.  Coeliac disease: is it time for mass screening?

Authors:  M Luisa Mearin; Annali Ivarsson; William Dickey
Journal:  Best Pract Res Clin Gastroenterol       Date:  2005-06       Impact factor: 3.043

Review 4.  Genetic insights into common pathways and complex relationships among immune-mediated diseases.

Authors:  Miles Parkes; Adrian Cortes; David A van Heel; Matthew A Brown
Journal:  Nat Rev Genet       Date:  2013-08-06       Impact factor: 53.242

Review 5.  Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists.

Authors:  Pekka Collin; Timo Reunala
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

6.  High rate of spontaneous normalization of celiac serology in a cohort of 446 children with type 1 diabetes: a prospective study.

Authors:  Stefania Castellaneta; Elvira Piccinno; Marica Oliva; Fernanda Cristofori; Marcella Vendemiale; Federica Ortolani; Francesco Papadia; Carlo Catassi; Luciano Cavallo; Ruggiero Francavilla
Journal:  Diabetes Care       Date:  2015-03-17       Impact factor: 19.112

7.  Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice.

Authors:  Daniele Sblattero; Francesco Maurano; Giuseppe Mazzarella; Mauro Rossi; Salvatore Auricchio; Fiorella Florian; Fabiana Ziberna; Alberto Tommasini; Tarcisio Not; Alessandro Ventura; Andrew Bradbury; Roberto Marzari; Riccardo Troncone
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

8.  Prevalence of Celiac disease among children in Finland.

Authors:  Markku Mäki; Kirsi Mustalahti; Jorma Kokkonen; Petri Kulmala; Mila Haapalahti; Tuomo Karttunen; Jorma Ilonen; Kaija Laurila; Ingrid Dahlbom; Tony Hansson; Peter Höpfl; Mikael Knip
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

Review 9.  Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules.

Authors:  Ludvig M Sollid; Shuo-Wang Qiao; Robert P Anderson; Carmen Gianfrani; Frits Koning
Journal:  Immunogenetics       Date:  2012-02-10       Impact factor: 2.846

10.  Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population.

Authors:  Sigrid Næss; Benedicte A Lie; Espen Melum; Marita Olsson; Johannes R Hov; Peter J P Croucher; Jochen Hampe; Erik Thorsby; Annika Bergquist; James A Traherne; Erik Schrumpf; Kirsten Muri Boberg; Stefan Schreiber; Andre Franke; Tom H Karlsen
Journal:  PLoS One       Date:  2014-12-18       Impact factor: 3.240

View more
  38 in total

Review 1.  Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases.

Authors:  Shintaro Akiyama; Soma Fukuda; Joshua M Steinberg; Hideo Suzuki; Kiichiro Tsuchiya
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

Review 2.  Breaking Down Barriers: How Understanding Celiac Disease Pathogenesis Informed the Development of Novel Treatments.

Authors:  Francesco Valitutti; Alessio Fasano
Journal:  Dig Dis Sci       Date:  2019-07       Impact factor: 3.487

Review 3.  To screen or not to screen? Celiac antibodies in liver diseases.

Authors:  Janaína Luz Narciso-Schiavon; Leonardo Lucca Schiavon
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

4.  Whole exome sequencing of a consanguineous family identifies the possible modifying effect of a globally rare AK5 allelic variant in celiac disease development among Saudi patients.

Authors:  Jumana Yousuf Al-Aama; Noor Ahmad Shaik; Babajan Banaganapalli; Mohammed A Salama; Omran Rashidi; Ahmed N Sahly; Mohammed O Mohsen; Harbi A Shawoosh; Hebah Ahmad Shalabi; Mohammad Al Edreesi; Sameer E Alharthi; Jun Wang; Ramu Elango; Omar I Saadah
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

5.  Increased Frequency of Immune Thrombocytopenic Purpura in Coeliac Disease and Vice Versa: A Prospective Observational Study.

Authors:  Stefano Bibbò; Claudio Fozza; Giovanni Mario Pes; Rodrigo Rojas; Roberto Manetti; Maria Pina Dore
Journal:  Gastroenterol Res Pract       Date:  2018-04-23       Impact factor: 2.260

6.  The possible link between coeliac and Kawasaki diseases in Brazil: a cross-sectional study.

Authors:  Alessandra Dos Santos Domingues; Nicole Selleski; Rosa Harumi Uenishi; Cristina Medeiros Ribeiro de Magalhães; Lenora Gandolfi; Claudia B Pratesi
Journal:  BMJ Open       Date:  2018-02-14       Impact factor: 2.692

Review 7.  Celiac Disease and the Thyroid: Highlighting the Roles of Vitamin D and Iron.

Authors:  Christina Starchl; Mario Scherkl; Karin Amrein
Journal:  Nutrients       Date:  2021-05-21       Impact factor: 5.717

8.  Chronic autoimmune disorders are increased in coeliac disease: A case-control study.

Authors:  Stefano Bibbò; Giovanni Mario Pes; Paolo Usai-Satta; Roberta Salis; Sara Soro; Bianca Maria Quarta Colosso; Maria Pina Dore
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

Review 9.  Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder.

Authors:  Margaret R Dunne; Greg Byrne; Fernando G Chirdo; Conleth Feighery
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

Review 10.  Gut microbiota in Celiac Disease: microbes, metabolites, pathways and therapeutics.

Authors:  Katherine L Olshan; Maureen M Leonard; Gloria Serena; Ali R Zomorrodi; Alessio Fasano
Journal:  Expert Rev Clin Immunol       Date:  2020-12-27       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.